CXCL1 and Ewing sarcoma: Furthermore, Ewing sarcoma cells overexpressing AES (amino enhancer of split), a dominant-negative Gro/TLE protein, or treated with the HDAC inhibitor vorinostat display diminished transformation, consistent with NKX2-2 recruitment of Gro/TLE co-repressors and HDACs.